Healthcare Sector Stocks
The Healthcare sector has a total of 1053 stocks, with a combined market cap of $9.2 trillion, total revenue of $4.61 trillion and a weighted average PE ratio of 45.49.
Market Cap
9.2T
Revenue
4.61T
Profits
202.16B
PE Ratio
45.49
Profit Margin
4.39%
Dividend Yield
0.39%
1053 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | -0.87% | 2,173,484 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 639.90B | -0.45% | 6,111,696 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 465.20B | 0.04% | 5,564,772 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 381.94B | -1.92% | 5,261,193 | 450.13B |
| 5 | MRK | Merck & Co., Inc. | 321.97B | -1.11% | 7,533,656 | 65.77B |
| 6 | NVS | Novartis AG | 300.66B | -0.64% | 1,627,195 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 270.63B | 0.48% | 2,251,195 | 61.37B |
| 8 | NVO | Novo Nordisk A/S | 227.60B | 1.22% | 8,712,968 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 214.22B | 0.01% | 2,547,112 | 46.34B |
| 10 | AMGN | Amgen Inc. | 209.21B | -1.39% | 3,005,467 | 37.22B |
| 11 | ABT | Abbott Laboratories | 186.88B | 0.68% | 12,158,909 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 164.79B | -1.18% | 7,766,614 | 29.74B |
| 13 | PFE | Pfizer Inc. | 143.34B | -0.40% | 30,398,703 | 63.32B |
| 14 | DHR | Danaher Corporation | 138.13B | -1.29% | 8,213,873 | 25.11B |
| 15 | CVS | CVS Health Corporation | 135.15B | -3.13% | 7,718,978 | 405.62B |
| 16 | SYK | Stryker Corporation | 135.04B | 1.63% | 1,858,100 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 128.85B | -0.79% | 10,591,372 | 48.48B |
| 18 | ISRG | Intuitive Surgical, Inc. | 124.74B | -2.40% | 2,737,517 | 11.03B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 122.67B | -1.44% | 1,451,975 | 12.22B |
| 20 | MDT | Medtronic plc | 112.06B | 0.76% | 8,290,304 | 36.36B |
| 21 | SNY | Sanofi | 109.34B | -1.52% | 3,511,912 | 54.60B |
| 22 | GSK | GSK plc | 106.84B | -0.91% | 6,308,623 | 44.05B |
| 23 | MCK | McKesson Corporation | 104.03B | -0.11% | 837,945 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 88.37B | -2.39% | 1,850,258 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 81.54B | -2.53% | 1,061,495 | 201.11B |
| 26 | CI | The Cigna Group | 78.43B | -1.52% | 1,719,285 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 70.75B | 0.03% | 1,022,488 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 68.43B | -0.04% | 51,239,097 | 21.00B |
| 29 | COR | Cencora, Inc. | 61.99B | -0.30% | 986,643 | 328.68B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 56.98B | 1.31% | 5,238,771 | 28.34B |
| 31 | ARGX | argenx SE | 55.20B | 1.18% | 227,185 | 5.32B |
| 32 | CAH | Cardinal Health, Inc. | 53.66B | -1.46% | 2,842,621 | 250.74B |
| 33 | MDLN | Medline Inc. | 52.65B | -1.06% | 3,651,421 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 49.38B | 2.49% | 5,594,392 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 46.40B | 1.24% | 2,125,613 | 22.23B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.95B | 0.04% | 455,095 | 4.45B |
| 37 | HLN | Haleon plc | 44.43B | 0.10% | 28,681,035 | 14.85B |
| 38 | HUM | Humana Inc. | 43.87B | -5.99% | 4,110,395 | 145.68B |
| 39 | IQV | IQVIA Holdings Inc. | 40.75B | 1.90% | 2,241,881 | 16.98B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 40.42B | 9.60% | 17,760,898 | 17.32B |
| 41 | A | Agilent Technologies, Inc. | 39.63B | -0.17% | 1,864,814 | 7.23B |
| 42 | RVMD | Revolution Medicines, Inc. | 38.46B | -1.60% | 2,299,333 | - |
| 43 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.27B | -0.62% | 1,301,404 | 4.29B |
| 44 | WAT | Waters Corporation | 37.26B | -1.15% | 723,010 | 3.77B |
| 45 | ONC | BeOne Medicines AG | 36.38B | -0.98% | 189,369 | 5.74B |
| 46 | NTRA | Natera, Inc. | 36.35B | 0.63% | 923,839 | 2.50B |
| 47 | RPRX | Royalty Pharma plc | 34.08B | -1.32% | 2,599,404 | 2.44B |
| 48 | ALC | Alcon Inc. | 33.98B | 0.78% | 3,174,175 | 10.63B |
| 49 | VEEV | Veeva Systems Inc. | 33.77B | 3.33% | 2,073,954 | 3.32B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 32.71B | 12.15% | 15,272,170 | 21.27B |
| 51 | ZTS | Zoetis Inc. | 32.67B | 0.54% | 5,319,311 | 9.53B |
| 52 | RMD | ResMed Inc. | 30.91B | 2.55% | 1,323,070 | 5.54B |
| 53 | BIIB | Biogen Inc. | 30.89B | 1.76% | 2,400,052 | 10.03B |
| 54 | CNC | Centene Corporation | 30.54B | -3.27% | 8,348,252 | 180.30B |
| 55 | ILMN | Illumina, Inc. | 29.48B | 0.95% | 1,694,187 | 4.39B |
| 56 | DXCM | DexCom, Inc. | 28.99B | 0.39% | 6,268,963 | 4.82B |
| 57 | MTD | Mettler-Toledo International Inc. | 28.05B | - | 165,864 | 4.09B |
| 58 | DGX | Quest Diagnostics Incorporated | 25.96B | -0.31% | 964,534 | 11.56B |
| 59 | INCY | Incyte Corporation | 25.76B | -2.18% | 2,917,666 | 5.82B |
| 60 | PHG | Koninklijke Philips N.V. | 25.36B | 2.15% | 1,694,115 | 20.18B |
| 61 | LH | Labcorp Holdings Inc. | 25.19B | -2.25% | 1,193,255 | 14.14B |
| 62 | WST | West Pharmaceutical Services, Inc. | 23.75B | 0.20% | 922,065 | 3.33B |
| 63 | ROIV | Roivant Sciences Ltd. | 23.64B | -2.87% | 4,824,299 | 8.26M |
| 64 | BNTX | BioNTech SE | 23.51B | 0.54% | 739,945 | 3.23B |
| 65 | STE | STERIS plc | 22.89B | 1.95% | 922,580 | 5.94B |
| 66 | INSM | Insmed Incorporated | 22.35B | -0.97% | 2,195,002 | 819.56M |
| 67 | UTHR | United Therapeutics Corporation | 22.27B | 0.20% | 560,605 | 3.17B |
| 68 | THC | Tenet Healthcare Corporation | 22.19B | -1.91% | 1,284,151 | 21.81B |
| 69 | MRNA | Moderna, Inc. | 21.62B | -2.37% | 4,351,856 | 2.23B |
| 70 | VTRS | Viatris Inc. | 20.75B | -0.22% | 10,028,107 | 14.56B |
| 71 | GH | Guardant Health, Inc. | 19.10B | 0.31% | 2,743,567 | 1.08B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 18.79B | 1.46% | 3,613,136 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 18.18B | -1.12% | 1,072,192 | 3.10B |
| 74 | GMAB | Genmab A/S | 17.45B | -1.66% | 1,160,855 | 3.90B |
| 75 | ASND | Ascendis Pharma A/S | 16.62B | -0.94% | 507,079 | 998.25M |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.33B | -2.35% | 2,400,883 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 16.33B | 2.44% | 580,868 | 2.78B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 16.08B | -0.37% | 622,516 | 4.44B |
| 79 | DVA | DaVita Inc. | 15.47B | 0.63% | 694,572 | 13.84B |
| 80 | SOLV | Solventum Corporation | 15.33B | 2.76% | 1,764,775 | 8.26B |
| 81 | BTSG | BrightSpring Health Services, Inc. | 14.45B | -4.26% | 1,972,240 | 13.65B |
| 82 | COO | The Cooper Companies, Inc. | 14.25B | 1.39% | 1,739,272 | 4.23B |
| 83 | EXEL | Exelixis, Inc. | 13.91B | -2.09% | 1,882,640 | 2.38B |
| 84 | ICLR | ICON Public Limited Company | 13.65B | -1.14% | 1,571,935 | 8.27B |
| 85 | SNN | Smith & Nephew plc | 13.57B | 0.31% | 3,252,181 | 6.16B |
| 86 | ELAN | Elanco Animal Health Incorporated | 13.18B | 3.41% | 6,613,920 | 4.89B |
| 87 | FMS | Fresenius Medical Care AG | 13.14B | 0.44% | 499,393 | 22.32B |
| 88 | ALGN | Align Technology, Inc. | 12.90B | 2.55% | 1,658,257 | 4.14B |
| 89 | BAX | Baxter International Inc. | 12.79B | 1.64% | 9,427,009 | 11.32B |
| 90 | RVTY | Revvity, Inc. | 12.65B | 1.67% | 2,331,490 | 2.90B |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.61B | 1.50% | 356,837 | 1.13B |
| 92 | PEN | Penumbra, Inc. | 12.59B | 0.04% | 365,271 | 1.45B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.14B | 0.51% | 1,808,802 | 622.01M |
| 94 | BMRN | BioMarin Pharmaceutical Inc. | 11.86B | -1.13% | 1,805,383 | 3.24B |
| 95 | PODD | Insulet Corporation | 11.82B | 1.88% | 1,126,102 | 2.90B |
| 96 | AXSM | Axsome Therapeutics, Inc. | 11.70B | -2.89% | 522,973 | 708.24M |
| 97 | CRL | Charles River Laboratories International, Inc. | 11.31B | -2.34% | 1,054,398 | 4.03B |
| 98 | EHC | Encompass Health Corporation | 11.29B | -1.92% | 758,709 | 6.07B |
| 99 | TECH | Bio-Techne Corporation | 11.22B | -0.06% | 6,272,480 | 1.21B |
| 100 | GMED | Globus Medical, Inc. | 11.05B | 1.04% | 1,336,575 | 3.10B |
| 101 | KRYS | Krystal Biotech, Inc. | 10.71B | -0.26% | 355,853 | 417.30M |
| 102 | CYTK | Cytokinetics, Incorporated | 10.64B | -1.34% | 1,780,883 | 105.82M |
| 103 | ABVX | ABIVAX Société Anonyme | 10.63B | -4.34% | 1,150,516 | 5.67M |
| 104 | ENSG | The Ensign Group, Inc. | 10.51B | -0.68% | 653,843 | 5.49B |
| 105 | MOH | Molina Healthcare, Inc. | 10.37B | -0.66% | 1,068,218 | 42.47B |
| 106 | SMMT | Summit Therapeutics Inc. | 10.21B | 1.99% | 3,777,811 | - |
| 107 | UHS | Universal Health Services, Inc. | 10.18B | 1.17% | 1,390,880 | 18.11B |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.08B | 0.02% | 1,084,497 | - |
| 109 | CORT | Corcept Therapeutics Incorporated | 9.98B | -1.32% | 1,550,618 | 769.10M |
| 110 | RDY | Dr. Reddy's Laboratories Limited | 9.94B | 0.26% | 2,335,441 | 3.50B |
| 111 | HALO | Halozyme Therapeutics, Inc. | 9.88B | -0.20% | 1,634,176 | 1.51B |
| 112 | HSIC | Henry Schein, Inc. | 9.78B | 0.14% | 1,744,910 | 13.38B |
| 113 | AVTR | Avantor, Inc. | 9.73B | 15.78% | 42,778,954 | 6.56B |
| 114 | GKOS | Glaukos Corporation | 9.49B | 6.83% | 3,136,449 | 551.35M |
| 115 | BRKR | Bruker Corporation | 9.40B | -1.86% | 2,655,391 | 3.46B |
| 116 | OSCR | Oscar Health, Inc. | 9.21B | -2.64% | 5,663,965 | 13.30B |
| 117 | IONS | Ionis Pharmaceuticals, Inc. | 8.93B | -2.28% | 3,129,417 | 873.71M |
| 118 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.84B | 0.02% | 1,621,551 | 18.07M |
| 119 | BIO | Bio-Rad Laboratories, Inc. | 8.76B | -1.13% | 361,770 | 2.59B |
| 120 | HQY | HealthEquity, Inc. | 8.71B | 2.85% | 885,768 | 1.34B |
| 121 | ATR | AptarGroup, Inc. | 8.69B | -1.15% | 579,852 | 3.87B |
| 122 | KYMR | Kymera Therapeutics, Inc. | 8.66B | -0.86% | 505,613 | 51.48M |
| 123 | QGEN | Qiagen N.V. | 8.65B | -1.11% | 1,516,376 | 2.10B |
| 124 | SYRE | Spyre Therapeutics, Inc. | 8.61B | -2.09% | 1,216,578 | - |
| 125 | PTGX | Protagonist Therapeutics, Inc. | 8.55B | -2.81% | 560,631 | 74.06M |
| 126 | PRAX | Praxis Precision Medicines, Inc. | 8.11B | -1.62% | 339,735 | 7.46M |
| 127 | ALKS | Alkermes plc | 8.11B | -4.28% | 4,149,634 | 1.67B |
| 128 | RGEN | Repligen Corporation | 7.97B | -2.83% | 1,514,002 | 785.10M |
| 129 | IMVT | Immunovant, Inc. | 7.97B | -0.75% | 1,620,326 | - |
| 130 | LQDA | Liquidia Corporation | 7.72B | - | 1,160,947 | 288.07M |
| 131 | PCVX | Vaxcyte, Inc. | 7.65B | -2.97% | 1,142,192 | - |
| 132 | TGTX | TG Therapeutics, Inc. | 7.58B | -2.53% | 2,916,135 | 700.35M |
| 133 | TEM | Tempus AI, Inc. | 7.48B | -3.15% | 4,407,001 | 1.36B |
| 134 | PACS | PACS Group, Inc. | 7.35B | -1.04% | 857,679 | 5.43B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.30B | -1.40% | 502,052 | 217.17M |
| 136 | IBRX | ImmunityBio, Inc. | 7.15B | -2.01% | 8,625,097 | 140.98M |
| 137 | CHE | Chemed Corporation | 7.13B | 4.20% | 286,056 | 2.60B |
| 138 | GRFS | Grifols, S.A. | 7.09B | 1.88% | 1,903,047 | 8.48B |
| 139 | COGT | Cogent Biosciences, Inc. | 6.76B | -2.70% | 1,220,915 | - |
| 140 | MIRM | Mirum Pharmaceuticals, Inc. | 6.56B | -4.15% | 682,485 | 569.61M |
| 141 | LNTH | Lantheus Holdings, Inc. | 6.51B | -2.57% | 1,560,668 | 1.55B |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.31B | 1.86% | 1,380,525 | 840.85M |
| 143 | PTCT | PTC Therapeutics, Inc. | 6.18B | -1.19% | 1,173,843 | 827.11M |
| 144 | ERAS | Erasca, Inc. | 6.15B | -2.42% | 4,196,031 | - |
| 145 | XENE | Xenon Pharmaceuticals Inc. | 6.10B | -2.83% | 703,481 | 7.50M |
| 146 | CGON | CG Oncology, Inc. | 6.10B | -4.82% | 1,104,142 | 5.07M |
| 147 | BLLN | BillionToOne, Inc. | 6.10B | -0.84% | 610,834 | 354.54M |
| 148 | AMRX | Amneal Pharmaceuticals, Inc. | 6.09B | 1.81% | 1,969,649 | 3.05B |
| 149 | BLTE | Belite Bio, Inc | 6.00B | -2.25% | 251,436 | - |
| 150 | TFX | Teleflex Incorporated | 5.96B | 0.34% | 548,888 | 2.13B |
| 151 | TXG | 10x Genomics, Inc. | 5.88B | -1.55% | 2,390,827 | 638.78M |
| 152 | SRRK | Scholar Rock Holding Corporation | 5.88B | -0.63% | 1,087,608 | - |
| 153 | HIMS | Hims & Hers Health, Inc. | 5.79B | -14.73% | 29,246,852 | 2.37B |
| 154 | BLCO | Bausch + Lomb Corporation | 5.78B | -2.47% | 592,020 | 5.32B |
| 155 | HNGE | Hinge Health, Inc. | 5.73B | -1.58% | 1,128,276 | 646.34M |
| 156 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | -2.79% | 356,723 | 274.48M |
| 157 | DNTH | Dianthus Therapeutics, Inc. | 5.69B | 2.44% | 887,299 | 1.34M |
| 158 | DFTX | Definium Therapeutics, Inc. | 5.60B | 0.48% | 1,770,619 | - |
| 159 | STVN | Stevanato Group S.p.A. | 5.57B | 1.29% | 473,795 | 1.39B |
| 160 | TWST | Twist Bioscience Corporation | 5.32B | -3.48% | 1,459,873 | 409.48M |
| 161 | ORKA | Oruka Therapeutics, Inc. | 5.31B | -2.63% | 790,240 | - |
| 162 | MMED | MiniMed Group, Inc. | 5.17B | 4.31% | 1,636,019 | 3.10B |
| 163 | TVTX | Travere Therapeutics, Inc. | 5.17B | -0.63% | 1,158,192 | 536.20M |
| 164 | SHC | Sotera Health Company | 5.00B | -1.30% | 4,076,973 | 1.19B |
| 165 | RDNT | RadNet, Inc. | 4.98B | 0.24% | 865,906 | 2.14B |
| 166 | INDV | Indivior Pharmaceuticals, Inc. | 4.89B | -2.17% | 1,496,127 | 1.29B |
| 167 | MMSI | Merit Medical Systems, Inc. | 4.82B | 3.26% | 1,334,549 | 1.54B |
| 168 | WAY | Waystar Holding Corp. | 4.70B | 3.50% | 3,635,386 | 1.21B |
| 169 | CRSP | CRISPR Therapeutics AG | 4.69B | 0.19% | 1,894,614 | 4.10M |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.68B | -3.09% | 2,105,170 | - |
| 171 | NVST | Envista Holdings Corporation | 4.62B | 5.23% | 6,050,829 | 2.81B |
| 172 | ACAD | ACADIA Pharmaceuticals Inc. | 4.51B | 1.27% | 1,733,057 | 1.10B |
| 173 | MANE | Veradermics, Incorporated | 4.50B | -3.39% | 447,480 | - |
| 174 | LIVN | LivaNova PLC | 4.47B | -0.80% | 501,962 | 1.43B |
| 175 | VCYT | Veracyte, Inc. | 4.45B | 0.11% | 929,125 | 541.74M |
| 176 | CAI | Caris Life Sciences, Inc. | 4.41B | - | 5,624,918 | 907.29M |
| 177 | EWTX | Edgewise Therapeutics, Inc. | 4.28B | -1.49% | 698,413 | - |
| 178 | LFST | LifeStance Health Group, Inc. | 4.21B | -3.38% | 2,829,066 | 1.49B |
| 179 | ICUI | ICU Medical, Inc. | 4.16B | 0.45% | 303,336 | 2.16B |
| 180 | CELC | Celcuity Inc. | 4.06B | 0.97% | 1,371,568 | - |
| 181 | PBLS | Parabilis Medicines, Inc. | 4.05B | -0.56% | 361,137 | - |
| 182 | CON | Concentra Group Holdings Parent, Inc. | 4.04B | -3.30% | 773,304 | 2.23B |
| 183 | IRTC | iRhythm Holdings, Inc. | 4.02B | 4.32% | 917,996 | 787.85M |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.00B | 0.44% | 1,944,064 | 10.68M |
| 185 | DOCS | Doximity, Inc. | 3.89B | 0.89% | 3,136,764 | 644.86M |
| 186 | HAE | Haemonetics Corporation | 3.88B | 3.49% | 893,443 | 1.33B |
| 187 | VKTX | Viking Therapeutics, Inc. | 3.88B | -1.27% | 2,902,887 | - |
| 188 | DNLI | Denali Therapeutics Inc. | 3.79B | -0.83% | 1,375,851 | - |
| 189 | ALHC | Alignment Healthcare, Inc. | 3.78B | -0.76% | 3,815,167 | 4.26B |
| 190 | OPCH | Option Care Health, Inc. | 3.76B | 6.45% | 5,280,959 | 5.69B |
| 191 | TNGX | Tango Therapeutics, Inc. | 3.74B | -3.00% | 2,209,247 | 56.99M |
| 192 | ELVN | Enliven Therapeutics, Inc. | 3.70B | -1.47% | 853,982 | - |
| 193 | LEGN | Legend Biotech Corporation | 3.65B | -1.00% | 2,937,653 | 1.14B |
| 194 | ADPT | Adaptive Biotechnologies Corporation | 3.61B | 0.18% | 3,147,237 | 295.41M |
| 195 | NHC | National HealthCare Corporation | 3.57B | -1.01% | 81,379 | 1.53B |
| 196 | OGN | Organon & Co. | 3.56B | 0.15% | 2,600,165 | 6.16B |
| 197 | BKD | Brookdale Senior Living Inc. | 3.55B | -3.32% | 3,719,746 | 3.00B |
| 198 | ARQT | Arcutis Biotherapeutics, Inc. | 3.48B | -1.97% | 977,250 | 415.62M |
| 199 | TLX | Telix Pharmaceuticals Limited | 3.41B | -0.88% | 71,976 | 803.79M |
| 200 | ITGR | Integer Holdings Corporation | 3.39B | -0.56% | 407,701 | 1.86B |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.38B | -1.58% | 992,820 | 225.27M |
| 202 | GPCR | Structure Therapeutics Inc. | 3.37B | -1.13% | 403,700 | - |
| 203 | ALMS | Alumis Inc. | 3.36B | -2.40% | 820,821 | 8.40M |
| 204 | RCUS | Arcus Biosciences, Inc. | 3.33B | -2.22% | 856,151 | 236.00M |
| 205 | NAMS | NewAmsterdam Pharma Company N.V. | 3.26B | -0.25% | 1,301,202 | 22.57M |
| 206 | WRBY | Warby Parker Inc. | 3.19B | 0.12% | 2,079,734 | 890.57M |
| 207 | MBX | MBX Biosciences, Inc. | 3.04B | 6.49% | 564,612 | - |
| 208 | PRVA | Privia Health Group, Inc. | 3.04B | -2.86% | 781,617 | 2.25B |
| 209 | CLDX | Celldex Therapeutics, Inc. | 2.94B | 5.42% | 1,572,690 | 865.00K |
| 210 | XRAY | DENTSPLY SIRONA Inc. | 2.84B | 5.26% | 5,638,931 | 3.68B |
| 211 | IRON | Disc Medicine, Inc. | 2.81B | -1.31% | 358,387 | - |
| 212 | RGC | Regencell Bioscience Holdings Limited | 2.80B | -5.36% | 174,426 | - |
| 213 | QURE | uniQure N.V. | 2.75B | 9.30% | 3,859,202 | 18.67M |
| 214 | GRAL | GRAIL, Inc. | 2.72B | -1.52% | 518,335 | 156.12M |
| 215 | ESTA | Establishment Labs Holdings Inc. | 2.71B | 0.03% | 479,211 | 229.58M |
| 216 | SUPN | Supernus Pharmaceuticals, Inc. | 2.70B | -2.43% | 522,131 | 776.83M |
| 217 | TMDX | TransMedics Group, Inc. | 2.70B | 2.24% | 1,227,376 | 635.89M |
| 218 | ATAI | AtaiBeckley Inc. | 2.66B | - | 18,609,679 | 3.49M |
| 219 | IMNM | Immunome, Inc. | 2.62B | -0.47% | 794,063 | 4.02M |
| 220 | GRDN | Guardian Pharmacy Services, Inc. | 2.60B | -2.08% | 261,161 | 1.46B |
| 221 | BEAM | Beam Therapeutics Inc. | 2.59B | -1.03% | 1,577,531 | 164.01M |
| 222 | TRVI | Trevi Therapeutics, Inc. | 2.57B | -1.84% | 1,428,364 | - |
| 223 | ACHC | Acadia Healthcare Company, Inc. | 2.55B | -16.34% | 7,928,588 | 3.37B |
| 224 | TARS | Tarsus Pharmaceuticals, Inc. | 2.52B | -0.73% | 679,776 | 535.08M |
| 225 | KOD | Kodiak Sciences Inc. | 2.50B | -0.69% | 517,566 | - |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.47B | 0.91% | 386,299 | 1.09B |
| 227 | PGNY | Progyny, Inc. | 2.46B | 1.98% | 1,090,596 | 1.29B |
| 228 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -3.77% | 2,326,323 | 670.00M |
| 229 | NRIX | Nurix Therapeutics, Inc. | 2.45B | -2.28% | 1,170,209 | 36.77M |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.42B | -2.16% | 2,194,891 | 885.72M |
| 231 | NKTR | Nektar Therapeutics | 2.39B | -0.13% | 982,912 | 55.63M |
| 232 | VCEL | Vericel Corporation | 2.38B | -0.19% | 505,569 | 292.09M |
| 233 | PLSE | Pulse Biosciences, Inc. | 2.37B | -3.44% | 925,975 | 751.00K |
| 234 | LMAT | LeMaitre Vascular, Inc. | 2.37B | 1.24% | 313,348 | 256.28M |
| 235 | VERA | Vera Therapeutics, Inc. | 2.33B | -2.43% | 1,469,225 | - |
| 236 | MLYS | Mineralys Therapeutics, Inc. | 2.32B | -2.23% | 526,733 | - |
| 237 | NUVB | Nuvation Bio Inc. | 2.29B | -1.49% | 6,883,199 | 143.05M |
| 238 | PHVS | Pharvaris N.V. | 2.28B | -3.06% | 372,294 | - |
| 239 | CLOV | Clover Health Investments, Corp. | 2.23B | -2.42% | 5,046,378 | 2.21B |
| 240 | AXGN | Axogen, Inc. | 2.20B | 0.53% | 2,509,780 | 251.17M |
| 241 | VRDN | Viridian Therapeutics, Inc. | 2.20B | 1.90% | 2,045,589 | 70.92M |
| 242 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.19B | 0.92% | 2,070,717 | -665.00K |
| 243 | KLRA | Kailera Therapeutics, Inc. | 2.19B | 0.84% | 526,524 | - |
| 244 | ADUS | Addus HomeCare Corporation | 2.18B | -0.08% | 229,540 | 1.45B |
| 245 | HTFL | HeartFlow, Inc. | 2.16B | -2.15% | 1,002,033 | 191.42M |
| 246 | MD | Pediatrix Medical Group, Inc. | 2.14B | -0.48% | 553,154 | 1.93B |
| 247 | SGRY | Surgery Partners, Inc. | 2.13B | 5.33% | 2,972,612 | 3.34B |
| 248 | AVAH | Aveanna Healthcare Holdings Inc. | 2.12B | -1.42% | 1,648,394 | 2.52B |
| 249 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | -5.31% | 517,586 | - |
| 250 | AGIO | Agios Pharmaceuticals, Inc. | 2.08B | -2.72% | 1,155,275 | 66.05M |
| 251 | ATRC | AtriCure, Inc. | 2.08B | 2.87% | 1,387,853 | 569.62M |
| 252 | HRMY | Harmony Biosciences Holdings, Inc. | 2.08B | 0.25% | 467,296 | 899.11M |
| 253 | ZLAB | Zai Lab Limited | 2.06B | -1.66% | 577,608 | 453.28M |
| 254 | NEOG | Neogen Corporation | 2.05B | 2.29% | 2,743,536 | 870.56M |
| 255 | PVLA | Palvella Therapeutics, Inc. | 2.05B | -0.17% | 133,993 | - |
| 256 | IOVA | Iovance Biotherapeutics, Inc. | 2.04B | -2.98% | 10,794,318 | 285.61M |
| 257 | SION | Sionna Therapeutics, Inc. | 2.02B | -3.74% | 369,411 | - |
| 258 | BHVN | Biohaven Ltd. | 2.02B | -2.47% | 1,480,334 | - |
| 259 | ADMA | ADMA Biologics, Inc. | 2.02B | -0.91% | 2,185,169 | 509.86M |
| 260 | NEO | NeoGenomics, Inc. | 1.99B | 13.96% | 8,432,235 | 766.30M |
| 261 | SLS | SELLAS Life Sciences Group, Inc. | 1.99B | 0.10% | 5,493,947 | - |
| 262 | HCM | HUTCHMED (China) Limited | 1.98B | 1.70% | 43,377 | 548.51M |
| 263 | UFPT | UFP Technologies, Inc. | 1.97B | -1.15% | 181,039 | 608.85M |
| 264 | URGN | UroGen Pharma Ltd. | 1.97B | -1.05% | 317,736 | 140.49M |
| 265 | ZBIO | Zenas BioPharma, Inc. | 1.96B | -3.72% | 625,580 | 10.00M |
| 266 | RAPP | Rapport Therapeutics, Inc. | 1.96B | -2.43% | 323,967 | 20.00M |
| 267 | AUPH | Aurinia Pharmaceuticals Inc. | 1.95B | 1.47% | 884,144 | 298.30M |
| 268 | PGEN | Precigen, Inc. | 1.94B | -1.45% | 3,561,597 | 31.60M |
| 269 | FTRE | Fortrea Holdings Inc. | 1.94B | -1.45% | 3,155,494 | 2.68B |
| 270 | GHRS | GH Research PLC | 1.92B | 0.07% | 235,640 | - |
| 271 | SNDA | Sonida Senior Living, Inc. | 1.90B | -5.39% | 419,420 | 367.34M |
| 272 | NBTX | Nanobiotix S.A. | 1.90B | 0.08% | 176,599 | 38.27M |
| 273 | WGS | GeneDx Holdings Corp. | 1.89B | 2.92% | 1,026,402 | 442.68M |
| 274 | OMCL | Omnicell, Inc. | 1.88B | -3.83% | 1,309,404 | 1.23B |
| 275 | FBRX | Forte Biosciences, Inc. | 1.87B | -0.16% | 7,249,879 | - |
| 276 | BFLY | Butterfly Network, Inc. | 1.86B | -0.98% | 6,634,235 | 102.92M |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.85B | 0.74% | 496,078 | - |
| 278 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.53% | 255,328 | 1.20B |
| 279 | MESO | Mesoblast Limited | 1.84B | -2.21% | 251,269 | 65.38M |
| 280 | STOK | Stoke Therapeutics, Inc. | 1.84B | 0.31% | 700,137 | 32.08M |
| 281 | OCUL | Ocular Therapeutix, Inc. | 1.83B | -1.07% | 1,785,319 | 52.04M |
| 282 | CDNA | CareDx, Inc. | 1.83B | -0.95% | 744,410 | 412.82M |
| 283 | GLUE | Monte Rosa Therapeutics, Inc. | 1.82B | -2.18% | 1,233,803 | 42.95M |
| 284 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | 2.75% | 2,699,841 | 7.47M |
| 285 | NVCR | NovoCure Limited | 1.77B | -6.81% | 1,506,641 | 699.19M |
| 286 | KARD | Kardigan, Inc. | 1.76B | -6.00% | 162,763 | - |
| 287 | BHC | Bausch Health Companies Inc. | 1.75B | 3.54% | 3,637,406 | 10.53B |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.74B | -3.70% | 323,117 | - |
| 289 | ENOV | Enovis Corporation | 1.74B | 2.51% | 1,082,331 | 2.28B |
| 290 | ANIP | ANI Pharmaceuticals, Inc. | 1.73B | 0.91% | 288,342 | 923.71M |
| 291 | SNDX | Syndax Pharmaceuticals, Inc. | 1.70B | -2.09% | 1,747,138 | 217.17M |
| 292 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.70B | -3.94% | 1,931,689 | 204.73M |
| 293 | BCAX | Bicara Therapeutics Inc. | 1.70B | -3.68% | 509,359 | - |
| 294 | IMCR | Immunocore Holdings plc | 1.70B | -0.27% | 192,297 | 412.81M |
| 295 | ALMR | Alamar Biosciences, Inc. | 1.69B | -1.38% | 295,045 | 87.16M |
| 296 | GENB | Generate Biomedicines, Inc. | 1.68B | -0.46% | 748,908 | 30.30M |
| 297 | AAPG | Ascentage Pharma Group International | 1.67B | 0.11% | 4,291 | 82.08M |
| 298 | TDOC | Teladoc Health, Inc. | 1.66B | -1.92% | 8,245,248 | 2.49B |
| 299 | ABCL | AbCellera Biologics Inc. | 1.65B | 1.89% | 6,056,464 | 79.21M |
| 300 | ASTH | Astrana Health, Inc. | 1.64B | -3.85% | 500,625 | 3.53B |
| 301 | SRPT | Sarepta Therapeutics, Inc. | 1.64B | 0.68% | 2,860,568 | 2.18B |
| 302 | HCSG | Healthcare Services Group, Inc. | 1.61B | -1.35% | 752,784 | 1.86B |
| 303 | INVA | Innoviva, Inc. | 1.60B | -0.78% | 536,229 | 420.69M |
| 304 | RXRX | Recursion Pharmaceuticals, Inc. | 1.58B | -2.62% | 17,954,125 | 66.41M |
| 305 | ZYME | Zymeworks Inc. | 1.58B | -2.65% | 340,475 | 81.26M |
| 306 | ARDT | Ardent Health, Inc. | 1.57B | -4.71% | 763,654 | 6.43B |
| 307 | INNV | InnovAge Holding Corp. | 1.56B | -2.88% | 169,521 | 949.17M |
| 308 | TRLV | Trulieve Cannabis Corp. | 1.55B | -3.24% | 1,003,189 | 1.17B |
| 309 | AGL | agilon health, inc. | 1.55B | -6.54% | 336,110 | 5.82B |
| 310 | ANAB | AnaptysBio, Inc. | 1.54B | 0.06% | 428,441 | 232.39M |
| 311 | BLFS | BioLife Solutions, Inc. | 1.54B | -1.50% | 1,063,580 | 101.66M |
| 312 | XERS | Xeris Biopharma Holdings, Inc. | 1.52B | 1.70% | 1,193,928 | 314.85M |
| 313 | MLTX | MoonLake Immunotherapeutics | 1.52B | -1.76% | 707,856 | - |
| 314 | SEPN | Septerna, Inc. | 1.51B | -1.06% | 158,215 | 72.26M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.51B | -2.19% | 311,204 | 20.00M |
| 316 | NTLA | Intellia Therapeutics, Inc. | 1.51B | -0.83% | 3,489,846 | 66.09M |
| 317 | PAHC | Phibro Animal Health Corporation | 1.50B | 1.59% | 192,132 | 1.50B |
| 318 | ATEC | Alphatec Holdings, Inc. | 1.48B | 3.54% | 2,429,807 | 787.08M |
| 319 | INSP | Inspire Medical Systems, Inc. | 1.47B | -1.73% | 1,054,911 | 915.25M |
| 320 | CMPS | COMPASS Pathways plc | 1.47B | 0.46% | 2,767,188 | - |
| 321 | TRAX | First Tracks Biotherapeutics, Inc. | 1.46B | 0.05% | 582,191 | - |
| 322 | VIR | Vir Biotechnology, Inc. | 1.46B | -2.37% | 1,412,788 | 65.50M |
| 323 | XNCR | Xencor, Inc. | 1.45B | -2.20% | 1,161,146 | 97.36M |
| 324 | PRGO | Perrigo Company plc | 1.44B | 1.26% | 3,889,094 | 4.18B |
| 325 | HROW | Harrow, Inc. | 1.44B | -1.63% | 362,726 | 268.68M |
| 326 | AHCO | AdaptHealth Corp. | 1.44B | -3.83% | 928,714 | 3.29B |
| 327 | PNTG | The Pennant Group, Inc. | 1.43B | -2.24% | 258,929 | 1.02B |
| 328 | AVBP | ArriVent BioPharma, Inc. | 1.40B | 0.20% | 357,545 | - |
| 329 | AMN | AMN Healthcare Services, Inc. | 1.35B | 0.03% | 622,699 | 3.42B |
| 330 | SVRA | Savara Inc. | 1.34B | -0.94% | 1,259,484 | - |
| 331 | AORT | Artivion, Inc. | 1.34B | 2.00% | 759,259 | 458.69M |
| 332 | KMTS | Kestra Medical Technologies, Ltd. | 1.33B | -4.65% | 316,040 | 95.13M |
| 333 | ETON | Eton Pharmaceuticals, Inc. | 1.32B | 3.15% | 699,045 | 86.93M |
| 334 | AZTA | Azenta, Inc. | 1.30B | -2.25% | 692,781 | 596.48M |
| 335 | CNMD | CONMED Corporation | 1.30B | -2.35% | 763,050 | 1.37B |
| 336 | IART | Integra LifeSciences Holdings Corporation | 1.28B | -16.55% | 2,550,949 | 1.65B |
| 337 | TNDM | Tandem Diabetes Care, Inc. | 1.27B | 4.67% | 1,910,948 | 1.03B |
| 338 | ALVO | Alvotech | 1.26B | 13.87% | 3,137,982 | 562.04M |
| 339 | CERT | Certara, Inc. | 1.26B | 2.28% | 4,117,370 | 419.75M |
| 340 | AHG | Akso Health Group | 1.25B | - | 4,329 | 13.83M |
| 341 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.12% | 112,286 | - |
| 342 | AKTS | Aktis Oncology, Inc. | 1.24B | -2.53% | 314,875 | 8.28M |
| 343 | ARDX | Ardelyx, Inc. | 1.24B | -1.77% | 2,183,328 | 427.68M |
| 344 | MNKD | MannKind Corporation | 1.23B | -1.53% | 3,587,129 | 360.78M |
| 345 | IMTX | Immatics N.V. | 1.23B | 2.86% | 433,921 | 43.00M |
| 346 | PSNL | Personalis, Inc. | 1.23B | -1.26% | 2,064,910 | 64.52M |
| 347 | USPH | U.S. Physical Therapy, Inc. | 1.22B | 1.08% | 419,436 | 787.69M |
| 348 | NVAX | Novavax, Inc. | 1.21B | -0.41% | 2,326,748 | 596.34M |
| 349 | IRMD | IRADIMED CORPORATION | 1.20B | -0.60% | 111,505 | 86.28M |
| 350 | STAA | STAAR Surgical Company | 1.19B | 5.34% | 842,903 | 290.38M |
| 351 | COLL | Collegium Pharmaceutical, Inc. | 1.18B | 1.09% | 349,626 | 796.33M |
| 352 | ABSI | Absci Corporation | 1.17B | -3.23% | 3,503,056 | 1.84M |
| 353 | ORIC | ORIC Pharmaceuticals, Inc. | 1.17B | -5.29% | 1,867,906 | - |
| 354 | OMDA | Omada Health, Inc. | 1.17B | -4.01% | 840,852 | 283.30M |
| 355 | INBX | Inhibrx Biosciences, Inc. | 1.16B | -0.54% | 214,198 | 1.30M |
| 356 | JBIO | Jade Biosciences, Inc. | 1.15B | -1.78% | 635,764 | - |
| 357 | FRNM | Freenome, Inc. | 1.14B | -6.59% | 595,418 | 34.24M |
| 358 | SDGR | Schrödinger, Inc. | 1.13B | -1.11% | 662,038 | 254.91M |
| 359 | QDEL | QuidelOrtho Corporation | 1.13B | -1.02% | 1,188,022 | 2.66B |
| 360 | LBRX | LB Pharmaceuticals Inc | 1.12B | 11.62% | 709,074 | - |
| 361 | WVE | Wave Life Sciences Ltd. | 1.12B | -1.36% | 2,298,488 | 71.80M |
| 362 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | -2.03% | 646,671 | - |
| 363 | BVS | Bioventus Inc. | 1.10B | -0.68% | 808,360 | 576.30M |
| 364 | GDRX | GoodRx Holdings, Inc. | 1.09B | 3.21% | 1,548,992 | 787.89M |
| 365 | MGTX | MeiraGTx Holdings plc | 1.08B | -1.69% | 520,237 | 79.76M |
| 366 | CRON | Cronos Group Inc. | 1.07B | 0.35% | 1,062,215 | 159.54M |
| 367 | VOR | Vor Biopharma Inc. | 1.06B | -2.25% | 884,860 | - |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 1.06B | -1.49% | 544,507 | - |
| 369 | IVA | Inventiva S.A. | 1.06B | -2.80% | 1,176,676 | 7.94M |
| 370 | SPTX | Seaport Therapeutics, Inc. | 1.06B | -0.80% | 77,379 | - |
| 371 | PCRX | Pacira BioSciences, Inc. | 1.04B | -1.53% | 569,935 | 734.86M |
| 372 | ANRO | Alto Neuroscience, Inc. | 1.04B | -2.55% | 300,205 | - |
| 373 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.03B | -0.85% | 2,476,258 | 69.64M |
| 374 | OPK | OPKO Health, Inc. | 1.02B | -17.27% | 9,207,358 | 587.90M |
| 375 | PRCT | PROCEPT BioRobotics Corporation | 1.02B | -1.11% | 991,908 | 322.02M |
| 376 | DRTS | Alpha Tau Medical Ltd. | 1.01B | -3.20% | 688,756 | - |
| 377 | AVTX | Avalo Therapeutics, Inc. | 1.01B | -2.61% | 789,546 | 59.00K |
| 378 | GMRS | GMR Solutions Inc. | 1.00B | -0.54% | 430,193 | 5.83B |
| 379 | EYPT | EyePoint, Inc. | 999.39M | -0.33% | 2,054,153 | 7.61M |
| 380 | LMRI | Lumexa Imaging Holdings, Inc. | 989.63M | -6.11% | 400,375 | 1.03B |
| 381 | BIOA | BioAge Labs, Inc. | 986.41M | 1.23% | 1,037,070 | 10.32M |
| 382 | OLMA | Olema Pharmaceuticals, Inc. | 977.42M | -3.70% | 656,476 | - |
| 383 | NUTX | Nutex Health Inc. | 966.76M | -5.73% | 92,895 | 879.95M |
| 384 | SANA | Sana Biotechnology, Inc. | 950.68M | -3.65% | 3,091,445 | - |
| 385 | PHAT | Phathom Pharmaceuticals, Inc. | 924.57M | -0.17% | 729,392 | 204.89M |
| 386 | JANX | Janux Therapeutics, Inc. | 912.33M | -0.27% | 602,866 | 13.73M |
| 387 | AMPH | Amphastar Pharmaceuticals, Inc. | 907.43M | 2.13% | 321,672 | 720.53M |
| 388 | GERN | Geron Corporation | 898.13M | -3.45% | 5,655,892 | 196.12M |
| 389 | PHAR | Pharming Group N.V. | 882.92M | -6.61% | 3,476 | 366.48M |
| 390 | TALK | Talkspace, Inc. | 874.42M | 0.19% | 786,273 | 238.37M |
| 391 | TBPH | Theravance Biopharma, Inc. | 873.31M | -0.24% | 444,148 | 109.78M |
| 392 | INMD | InMode Ltd. | 870.83M | -2.07% | 866,662 | 374.64M |
| 393 | ODTX | Odyssey Therapeutics, Inc. | 864.20M | -2.06% | 200,542 | 1.06M |
| 394 | HSTM | HealthStream, Inc. | 862.72M | 2.36% | 158,562 | 311.78M |
| 395 | ABUS | Arbutus Biopharma Corporation | 847.44M | -2.72% | 2,077,598 | 191.45M |
| 396 | OMER | Omeros Corporation | 844.62M | 3.46% | 1,686,051 | 9.89M |
| 397 | SIBN | SI-BONE, Inc. | 817.80M | 2.84% | 596,651 | 206.22M |
| 398 | DBVT | DBV Technologies S.A. | 808.24M | 1.70% | 419,988 | 5.04M |
| 399 | GLAS | Glass House Brands Inc. | 800.56M | -4.85% | 514,309 | 177.68M |
| 400 | ANNX | Annexon, Inc. | 796.27M | -2.21% | 3,464,074 | - |
| 401 | KURA | Kura Oncology, Inc. | 792.76M | -4.08% | 1,787,161 | 71.64M |
| 402 | SLDB | Solid Biosciences Inc. | 791.53M | 0.88% | 904,982 | - |
| 403 | AURA | Aura Biosciences, Inc. | 773.20M | -0.57% | 481,222 | - |
| 404 | SSII | SS Innovations International, Inc. | 770.51M | -2.04% | 71,399 | 48.47M |
| 405 | AVR | Anteris Technologies Global Corp. | 769.90M | -3.30% | 876,087 | 1.85M |
| 406 | TENX | Tenax Therapeutics, Inc. | 757.18M | -6.20% | 1,565,414 | - |
| 407 | DSGN | Design Therapeutics, Inc. | 750.73M | 1.26% | 555,047 | - |
| 408 | FTH | Faeth Therapeutics, Inc. | 745.78M | -0.91% | 260,315 | - |
| 409 | CSTL | Castle Biosciences, Inc. | 741.87M | 2.39% | 340,083 | 339.92M |
| 410 | SGP | SpyGlass Pharma, Inc. | 732.52M | 1.34% | 117,116 | - |
| 411 | RIGL | Rigel Pharmaceuticals, Inc. | 722.88M | 1.48% | 223,386 | 299.77M |
| 412 | MNPR | Monopar Therapeutics Inc. | 719.62M | -1.53% | 357,181 | - |
| 413 | ACRS | Aclaris Therapeutics, Inc. | 715.08M | -3.94% | 1,177,962 | 8.37M |
| 414 | EVO | Evotec SE | 701.94M | -1.53% | 72,954 | 859.03M |
| 415 | DRUG | Bright Minds Biosciences Inc. | 693.64M | -1.25% | 196,804 | - |
| 416 | CLYM | Climb Bio, Inc. | 693.42M | -1.46% | 895,257 | - |
| 417 | CTMX | CytomX Therapeutics, Inc. | 690.12M | -1.55% | 1,365,455 | 35.54M |
| 418 | CADL | Candel Therapeutics, Inc. | 688.74M | -2.89% | 1,441,344 | - |
| 419 | PHR | Phreesia, Inc. | 688.58M | 2.58% | 586,489 | 495.59M |
| 420 | MPLT | MapLight Therapeutics, Inc. | 681.09M | 22.01% | 3,093,127 | - |
| 421 | BBNX | Beta Bionics, Inc. | 676.00M | -3.99% | 1,673,553 | 110.24M |
| 422 | CBLL | CeriBell, Inc. | 672.72M | -0.56% | 273,118 | 95.07M |
| 423 | NGNE | Neurogene Inc. | 670.74M | 1.32% | 132,004 | 925.00K |
| 424 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 659.68M | -4.13% | 386,773 | - |
| 425 | OCS | Oculis Holding AG | 654.61M | -1.99% | 196,022 | 1.40M |
| 426 | NVCT | Nuvectis Pharma, Inc. | 652.26M | 4.39% | 287,507 | - |
| 427 | ACHV | Achieve Life Sciences, Inc. | 633.92M | -0.08% | 1,279,476 | - |
| 428 | MDXG | MiMedx Group, Inc. | 630.04M | -2.98% | 1,433,737 | 389.42M |
| 429 | GYRE | Gyre Therapeutics, Inc. | 628.80M | -5.84% | 66,082 | 117.05M |
| 430 | ALLO | Allogene Therapeutics, Inc. | 624.73M | 9.04% | 12,512,086 | 22.00K |
| 431 | TCMD | Tactile Systems Technology, Inc. | 618.04M | -1.23% | 272,177 | 343.52M |
| 432 | AGMB | AgomAb Therapeutics NV | 610.67M | -1.12% | 46,769 | - |
| 433 | CBIO | Crescent Biopharma, Inc. | 610.35M | -10.16% | 526,054 | 11.88M |
| 434 | ANGO | AngioDynamics, Inc. | 604.69M | 2.02% | 434,510 | 320.17M |
| 435 | RGNX | REGENXBIO Inc. | 593.58M | 0.21% | 1,089,563 | 87.82M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 586.02M | -6.32% | 1,252,788 | 361.51M |
| 437 | IMMX | Immix Biopharma, Inc. | 581.62M | -3.20% | 1,367,475 | - |
| 438 | BWAY | BrainsWay Ltd. | 580.05M | -8.59% | 169,190 | 56.22M |
| 439 | SPRY | ARS Pharmaceuticals, Inc. | 578.94M | 2.82% | 6,438,688 | 98.99M |
| 440 | ZVRA | Zevra Therapeutics, Inc. | 578.15M | 0.51% | 1,043,385 | 122.29M |
| 441 | CERS | Cerus Corporation | 575.06M | -1.71% | 1,887,601 | 216.56M |
| 442 | ALT | Altimmune, Inc. | 567.86M | -2.34% | 8,301,360 | 36.00K |
| 443 | CTKB | Cytek Biosciences, Inc. | 565.64M | -1.79% | 597,777 | 204.17M |
| 444 | CRMD | CorMedix Inc. | 564.07M | -2.18% | 1,362,178 | 400.05M |
| 445 | FLGT | Fulgent Genetics, Inc. | 557.79M | 0.05% | 217,084 | 320.35M |
| 446 | WEAV | Weave Communications, Inc. | 552.98M | 0.87% | 1,010,370 | 248.72M |
| 447 | PRME | Prime Medicine, Inc. | 547.27M | -1.94% | 2,196,168 | 4.03M |
| 448 | SLN | Silence Therapeutics plc | 545.55M | - | 595,347 | 839.00K |
| 449 | RLMD | Relmada Therapeutics, Inc. | 539.14M | -1.72% | 1,218,693 | - |
| 450 | CTNM | Contineum Therapeutics, Inc. | 537.62M | 1.55% | 174,501 | - |
| 451 | TECX | Tectonic Therapeutic, Inc. | 536.45M | -4.60% | 165,220 | - |
| 452 | ARVN | Arvinas, Inc. | 530.36M | 0.24% | 740,473 | 89.40M |
| 453 | VSTM | Verastem, Inc. | 528.12M | -3.53% | 2,249,708 | 49.59M |
| 454 | TLRY | Tilray Brands, Inc. | 523.06M | -0.99% | 12,360,387 | 915.45M |
| 455 | STTK | Shattuck Labs, Inc. | 518.36M | -0.88% | 712,545 | 1.00M |
| 456 | KIDS | OrthoPediatrics Corp. | 513.44M | 0.76% | 185,093 | 243.30M |
| 457 | NNNN | Anbio Biotechnology | 508.70M | 14.19% | 53,213 | 8.65M |
| 458 | ZURA | Zura Bio Limited | 504.44M | -4.15% | 422,949 | - |
| 459 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 460 | FDMT | 4D Molecular Therapeutics, Inc. | 502.37M | -2.44% | 529,904 | 88.24M |
| 461 | DNA | Ginkgo Bioworks Holdings, Inc. | 497.77M | -1.04% | 760,882 | 151.40M |
| 462 | OFIX | Orthofix Medical Inc. | 491.93M | -0.73% | 379,457 | 825.37M |
| 463 | SI | Shoulder Innovations, Inc. | 491.91M | -2.19% | 167,346 | 53.89M |
| 464 | RZLT | Rezolute, Inc. | 490.99M | -4.47% | 802,394 | - |
| 465 | HELP | Cybin Inc. | 490.29M | 4.08% | 1,825,255 | - |
| 466 | EIKN | Eikon Therapeutics, Inc. | 487.79M | -5.06% | 247,113 | - |
| 467 | ARTV | Artiva Biotherapeutics, Inc. | 486.85M | -4.84% | 392,654 | 251.00K |
| 468 | ANL | Adlai Nortye Ltd. | 484.40M | -4.57% | 86,164 | 5.00M |
| 469 | ASMB | Assembly Biosciences, Inc. | 483.39M | -1.80% | 153,276 | 71.10M |
| 470 | TOI | The Oncology Institute, Inc. | 476.92M | -3.64% | 997,854 | 545.76M |
| 471 | MYGN | Myriad Genetics, Inc. | 476.02M | -5.26% | 1,429,220 | 829.00M |
| 472 | VALN | Valneva SE | 475.90M | 0.20% | 8,957 | 180.25M |
| 473 | PRLD | Prelude Therapeutics Incorporated | 467.13M | 1.51% | 485,705 | 16.72M |
| 474 | SOPH | SOPHiA GENETICS SA | 465.62M | -0.36% | 157,960 | 81.18M |
| 475 | PROK | ProKidney Corp. | 465.17M | - | 581,108 | 889.00K |
| 476 | NPCE | NeuroPace, Inc. | 465.04M | -10.91% | 366,136 | 99.53M |
| 477 | VREX | Varex Imaging Corporation | 461.50M | -1.62% | 248,094 | 857.50M |
| 478 | REPL | Replimune Group, Inc. | 454.25M | 1.12% | 14,296,364 | - |
| 479 | AQST | Aquestive Therapeutics, Inc. | 451.68M | -4.26% | 2,584,958 | 50.27M |
| 480 | PRTA | Prothena Corporation plc | 448.14M | - | 641,214 | 57.94M |
| 481 | VMD | Viemed Healthcare, Inc. | 446.62M | -2.27% | 195,218 | 286.57M |
| 482 | PACB | Pacific Biosciences of California, Inc. | 434.84M | 0.72% | 7,337,925 | 160.03M |
| 483 | SGMT | Sagimet Biosciences Inc. | 434.73M | -3.16% | 465,041 | - |
| 484 | IKT | Inhibikase Therapeutics, Inc. | 431.88M | -4.33% | 685,350 | 1.00 |
| 485 | KYTX | Kyverna Therapeutics, Inc. | 429.82M | -5.61% | 1,060,825 | - |
| 486 | OVID | Ovid Therapeutics Inc. | 427.41M | -2.97% | 648,336 | 7.12M |
| 487 | CABA | Cabaletta Bio, Inc. | 427.20M | -4.03% | 2,163,449 | - |
| 488 | CLPT | ClearPoint Neuro, Inc. | 424.05M | -2.68% | 526,222 | 40.61M |
| 489 | SRTA | Strata Critical Medical, Inc. | 421.38M | -4.32% | 1,178,974 | 228.58M |
| 490 | SLBT | SL Science Holding Limited | 420.23M | -5.45% | 57,003 | 3.36M |
| 491 | BNTC | Benitec Biopharma Inc. | 413.97M | 1.35% | 27,581 | - |
| 492 | NRC | NRC Health | 405.15M | -18.08% | 233,060 | 140.00M |
| 493 | KMDA | Kamada Ltd. | 405.07M | -0.71% | 31,288 | 181.68M |
| 494 | OCGN | Ocugen, Inc. | 402.84M | -4.03% | 6,982,150 | 4.47M |
| 495 | DCTH | Delcath Systems, Inc. | 399.76M | 0.26% | 340,348 | 90.44M |
| 496 | EDIT | Editas Medicine, Inc. | 399.00M | -0.76% | 1,528,494 | 38.69M |
| 497 | CTEV | Claritev Corporation | 398.92M | 3.22% | 73,197 | 978.76M |
| 498 | EVMN | Evommune, Inc. | 398.00M | -1.78% | 308,007 | 10.00M |
| 499 | PBYI | Puma Biotechnology, Inc. | 397.52M | -2.01% | 200,258 | 227.18M |
| 500 | EOLS | Evolus, Inc. | 397.10M | -3.05% | 812,682 | 301.79M |